Skip to main content
Log in

Isoleucine/leucine residues at “a” and “d” positions of a heptad repeat sequence are crucial for the cytolytic activity of a short anticancer lytic peptide

  • Original Article
  • Published:
Amino Acids Aims and scope Submit manuscript

Abstract

Many lytic peptides contain a heptad sequence with leucine or isoleucine residues at “a” and “d” positions. However, their roles in the peptide-induced cytolytic process remain unclear. We have recently reported an anticancer lytic peptide ZXR-2 (FKIGGFIKKLWRSLLA), which contains a shortened zipper-like sequence with Ile/Leu at “a” and “d” positions. To understand the roles of these Ile/Leu residues, a series of analogs were constructed by sequentially replacing the Ile or Leu residue with alanine (Ala). Significant reduction of the cytolytic activity was observed when the Ile (3rd and 7th) and Leu (10th and 14th) residues at the “a” and “d” positions were substituted, while the replacement of the separate Leu (15th) residue had less effect. Based on the quenching of the intrinsic fluorescence of the peptides and their induced surface pressure changes of lipid monolayer, it was conjectured that the peptide ZXR-2 might insert into cell membranes from the C-terminal and to a depth of the W11 position. Accordingly, I3, I7, and L10 residues which mainly exposed in aqueous solution were more responsible for the peptide self-association on cell membranes, while L14, together with L15, might help peptide insert and anchor to cell membranes. These results are significant to elucidate the crucial roles of such Ile/Leu residues at “a” and “d” positions in peptide–peptide and peptide–membrane interactions to exert the membrane disruption activity of lytic peptides. With further understanding about the structure–activity relationship of lytic peptides, it would be helpful for designing novel anticancer lytic peptides.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  • Ahmad A, Yadav SP, Asthana N, Mitra K, Srivastava SP, Ghosh JK (2006) Utilization of an amphipathic leucine zipper sequence to design antibacterial peptides with simultaneous modulation of toxic activity against human red blood cells. J Biol Chem 281:22029–22038

    Article  CAS  PubMed  Google Scholar 

  • Ahmad A, Asthana N, Azmi S, Srivastava RM, Pandey BK, Yadav V, Ghosh JK (2009a) Structure-function study of cathelicidin-derived bovine antimicrobial peptide BMAP-28: design of its cell-selective analogs by amino acid substitutions in the heptad repeat sequences. Biochim Biophys Acta 1788:2411–2420

    Article  CAS  PubMed  Google Scholar 

  • Ahmad A, Azmi S, Srivastava RM, Srivastava S, Pandey BK, Saxena R, Bajpai VK, Ghosh JK (2009b) Design of nontoxic analogues of cathelicidin-derived bovine antimicrobial peptide BMAP-27: the role of leucine as well as phenylalanine zipper sequence in determining its toxicity. Biochemistry 48:10905–10917

    Article  CAS  PubMed  Google Scholar 

  • Ahmad A, Azmi S, Srivastava S, Kumar A, Tripathi JK, Mishra NN, Shukla PK, Ghosh JK (2014) Design and characterization of short antimicrobial peptides using leucine zipper templates with selectivity towards microorganisms. Amino Acids 46:2531–2543

    Article  CAS  PubMed  Google Scholar 

  • Asthana N, Yadav SP, Ghosh JK (2004) Dissection of antibacterial and toxic activity of melittin: a leucine zipper motif plays a crucial role in determining its hemolytic activity but not antibacterial activity. J Biol Chem 279:55042–55050

    Article  CAS  PubMed  Google Scholar 

  • Azmi S, Srivastava S, Mishra NN, Tripathi JK, Shukla PK, Ghosh JK (2013) Characterization of antimicrobial, cytotoxic, and antiendotoxin properties of short peptides with different hydrophobic amino acids at “a” and “d” positions of a heptad repeat sequence. J Med Chem 56:924–939

    Article  CAS  PubMed  Google Scholar 

  • Backer MV, Gaynutdinov TI, Patel V, Jehning BT, Myshkin E, Backer JM (2004) Adapter protein for site-specific conjugation of payloads for targeted drug delivery. Bioconjug Chem 15:1021–1029

    Article  CAS  PubMed  Google Scholar 

  • Barbosa SC, Cilli EM, Dias LG, Stabeli RG, Ciancaglini P (2011) Labaditin, a cyclic peptide with rich biotechnological potential: preliminary toxicological studies and structural changes in water and lipid membrane environment. Amino Acids 40:135–144

    Article  CAS  PubMed  Google Scholar 

  • Bechinger B (2004) Structure and function of membrane-lytic peptides. Crit Rev Plant Sci 23:1–22

    Article  Google Scholar 

  • Brogden NK, Brogden KA (2011) Will new generations of modified antimicrobial peptides improve their potential as pharmaceuticals? Int J Antimicrob Agents 38:217–225

    CAS  PubMed  PubMed Central  Google Scholar 

  • Chen L, Liang JF (2013) Peptide fibrils with altered stability, activity, and cell selectivity. Biomacromolecules 14:2326–2331

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Chen L, Tu Z, Voloshchuk N, Liang JF (2012) Lytic peptides with improved stability and selectivity designed for cancer treatment. J Pharm Sci 101:1508–1517

    Article  CAS  PubMed  Google Scholar 

  • Dathe M, Wieprecht T (1999) Structural features of helical antimicrobial peptides: their potential to modulate activity on model membranes and biological cells. Biochim Biophys Acta 1462:71–87

    Article  CAS  PubMed  Google Scholar 

  • Eisenberg D, Weiss RM, Terwilliger TC (1982) The helical hydrophobic moment: a measure of the amphiphilicity of a helix. Nature 299:371–374

    Article  CAS  PubMed  Google Scholar 

  • Falanga A, Tarallo R, Carberry T, Galdiero M, Weck M, Galdiero S (2014) Elucidation of the interaction mechanism with liposomes of gH625-peptide functionalized dendrimers. PLoS One 9:e112128

    Article  PubMed  PubMed Central  Google Scholar 

  • Fjell CD, Hiss JA, Hancock RE, Scheider G (2011) Designing antimicrobial peptides: form follows function. Nat Rev Drug Discov 11:37–51

    PubMed  Google Scholar 

  • Gautier R, Douguet D, Antonny B, Drin G (2008) HELIQUEST: a web server to screen sequences with specific α-helical properties. Bioinformatics 24:2101–2102

    Article  CAS  PubMed  Google Scholar 

  • Killion JJ, Dunn JD (1986) Differential cytolysis of murine spleen, bone-marrow and leukemia cells by melittin reveals differences in membrane topography. Biochem Biophys Res Commun 139:222–227

    Article  CAS  PubMed  Google Scholar 

  • Mader JS, Hoskin DW (2006) Cationic antimicrobial peptides as novel cytotoxic agents for cancer treatment. Expert Opin Investig Drugs 15:933–946

    Article  CAS  PubMed  Google Scholar 

  • Oren Z, Shai Y (1997) Selective lysis of bacteria but not mammalian cells by diastereomers of melittin: structure-function study. Biochemistry 36:1826–1835

    Article  CAS  PubMed  Google Scholar 

  • Oren Z, Shai Y (1998) Mode of action of linear amphipathic α-helical antimicrobial peptides. Biopolymers 47:451–463

    Article  CAS  PubMed  Google Scholar 

  • Pandey BK, Srivastava S, Singh M, Ghosh JK (2011) Inducing toxicity by introducing a leucine-zipper-like motif in frog antimicrobial peptide, magainin 2. Biochem J 436:609–620

    Article  CAS  PubMed  Google Scholar 

  • Shai Y (2002) From innate immunity to de-nove designed antimicrobial peptides. Curr Pharm Des 8:715–725

    Article  CAS  PubMed  Google Scholar 

  • Shai Y, Oren Z (1996) Diastereoisomers of cytolysins, a novel class of potent antibacterial peptides. J Biol Chem 271:7305–7308

    Article  CAS  PubMed  Google Scholar 

  • Shai Y, Oren Z (2001) From “carpet” mechanism to de-novo designed diastereomeric cell-selective antimicrobial peptides. Peptides 22:1629–1641

    Article  CAS  PubMed  Google Scholar 

  • Zhou XR, Zhang Q, Tian XB, Cao YM, Liu ZQ, Fan R, Ding XF, Zhu Z, Chen L, Luo SZ (2016) From a pro-apoptotic peptide to a lytic peptide: one single residue mutation. BBA-biomembranes. 1858:1914–1925

    Article  CAS  PubMed  Google Scholar 

  • Zhu WL, Song YM, Park Y, Park KH, Yang ST, Kin JI, Park IS, Hahm KS, Shin SY (2007) Substitution of the leucine zipper sequence in melittin with peptoid residues affects self-association, cell selectivity, and mode of action. Biochim Biophys Acta 1768:1506–1517

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

This work was supported by the National Basic Research Program of China (973 program; 2013CB910700), the National Natural Science Foundation of China (21372026, 21402006), Beijing NOVA Program (Z131102000413010), and the Fundamental Research Funds for the Central Universities (Grand No. 2050205, JC1502, 20130801, YS1407). We thank Dr. Feng Chen at Peking University School of Stomatology for the donation of Hela cells.

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Shi-Zhong Luo or Long Chen.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Research involving human participants and/or animals

This article does not contain any studies with human participants or animals performed by any of the authors.

Additional information

Handling Editor: G. J. Peters.

R. Fan and Y. Yuan are contributed equally to this work.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (DOCX 143 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Fan, R., Yuan, Y., Zhang, Q. et al. Isoleucine/leucine residues at “a” and “d” positions of a heptad repeat sequence are crucial for the cytolytic activity of a short anticancer lytic peptide. Amino Acids 49, 193–202 (2017). https://doi.org/10.1007/s00726-016-2350-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00726-016-2350-9

Keywords

Navigation